NEW YORK (GenomeWeb News) – As Venaxis prepares a submission to the US Food and Drug Administration for its appendicitis diagnostic test and a full European launch, the company announced this week the completion of the first futility analysis of the test.

As a result, an independent body has recommended a continuation of Venaxis' pivotal clinical trial for the test, called the APPY1 Test. The trial will include a second futility analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.